BioNTech SE
BNTX
$89.27
-$0.04-0.05%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.26B | -633.26M | -381.92M | -812.62M | -717.13M |
| Total Depreciation and Amortization | 210.06M | 273.71M | 177.32M | 173.15M | 169.68M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.01B | -62.97M | -337.72M | -254.54M | -549.30M |
| Change in Net Operating Assets | 659.35M | 186.09M | -1.31B | 627.61M | 1.31B |
| Cash from Operations | 617.72M | -236.43M | -1.85B | -266.41M | 210.70M |
| Capital Expenditure | -197.76M | -195.18M | -233.24M | -297.85M | -309.90M |
| Sale of Property, Plant, and Equipment | 5.18M | 5.23M | 2.17M | 1.82M | 1.29M |
| Cash Acquisitions | 225.64M | -82.61M | -82.61M | -82.61M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.05B | 1.08B | 2.04B | 1.92B | -1.96B |
| Cash from Investing | -3.02B | 803.92M | 1.73B | 1.54B | -2.27B |
| Total Debt Issued | 6.70M | -- | -- | -- | -- |
| Total Debt Repaid | -57.60M | -45.90M | -42.30M | -51.90M | -45.90M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.00M | -- | -- | -- | -- |
| Cash from Financing | -59.71M | -50.84M | -46.08M | -55.64M | -49.58M |
| Foreign Exchange rate Adjustments | -30.01M | -17.14M | 5.47M | -8.53M | 15.80M |
| Miscellaneous Cash Flow Adjustments | 8.16M | -18.45M | 23.37M | 59.47M | 3.45M |
| Net Change in Cash | -2.48B | 481.05M | -139.33M | 1.27B | -2.09B |